4.5 Article

Efficacy of micafungin for the treatment of invasive candidiasis and candidaemia in patients with neutropenia

Related references

Note: Only part of the references are listed.
Article Infectious Diseases

Efficacy of anidulafungin in 539 patients with invasive candidiasis: a patient-level pooled analysis of six clinical trials

Bart Jan Kullberg et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)

Article Infectious Diseases

A prospective, cohort, multicentre study of candidaemia in hospitalized adult patients with haematological malignancies

M. N. Gamaletsou et al.

CLINICAL MICROBIOLOGY AND INFECTION (2014)

Review Infectious Diseases

The PATH (Prospective Antifungal Therapy) Alliance® registry and invasive fungal infections: update 2012

Nkechi Azie et al.

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2012)

Article Infectious Diseases

Factors related to survival and treatment success in invasive candidiasis or candidemia: a pooled analysis of two large, prospective, micafungin trials

D. L. Horn et al.

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2010)

Article Immunology

Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis

Peter G. Pappas et al.

CLINICAL INFECTIOUS DISEASES (2007)

Article Medicine, General & Internal

Anidulafungin versus fluconazole for invasive candidiasis

Annette C. Reboli et al.

NEW ENGLAND JOURNAL OF MEDICINE (2007)

Article Infectious Diseases

Candidaemia and cancer: patients are not all the same

AC Pasqualotto et al.

BMC INFECTIOUS DISEASES (2006)

Article Public, Environmental & Occupational Health

Characteristics of candidaemia with Candida-albicans compared with non-albicans Candida species and predictors of mortality

M Weinberger et al.

JOURNAL OF HOSPITAL INFECTION (2005)

Review Oncology

Predictors of outcome in cancer patients with candidemia

O Uzun et al.

ANNALS OF ONCOLOGY (2000)